A drug developed by a consortium of Hungarian researchers, including ones from Budapest’s Eötvös Loránd University (ELTE) and pharmaceutical company Gedeon Richter, appears to be effective for the treatment of coronavirus based on animal tests, ELTE Imre Kacskovics, who heads the researchers, said on public radio on Tuesday, according to a report by Hungarian news agency MTI.
The animal tests show the drug not only inhibits infection by COVID-19 but alleviates symptoms after COVID-19 infection, Kacskovics said on Kossuth Rádió. He added that the drug starts to work within 12 hours after it is injected. The consortium developing the drug started its work in March.
Source: Budapest Business Journal
